In the test of multiplicity between GSTP and prostate cancer, the intercept was −0.006, with a p-value of 0.465, which was not statistically significant, and in the test of multiplicity between GSTO1 and prostate cancer, the intercept was −0.002, with a p-value of 0.749, which was not statistically significant. Here, GSTP1 is linked to prostate carcinoma.